LexDanaLexDanabeta
Inventor

Mark A. PAULIK

Inventor
US

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61MDevices for introducing media into, or onto, the body25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
PatentTitleYear
11,840,559Glucagon-receptor selective polypeptides and methods of use thereof202311,214,607Glucagon-receptor selective polypeptides and methods of use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to INTARCIA THERAPEUTICS INC (2)· patent assignee history
2022–2023Based in US· patent location history
2023Patents assigned to I2O THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTARCIA THERAPEUTICS INC22022–2023
I2O THERAPEUTICS INC12023
Locations
LocationPatentsSpan
US22022–2023